Serendipitous discovery of djerfisherite in Ryugu grain challenges current paradigm of the nature of primitive asteroids. A surprising discovery from a tiny grain of asteroid Ryugu has rocked scientists’ understanding of how our Solar System evolved. Researchers found djerfisherite—a mineral typically born in scorching, chemically reduced conditions and never before seen in Ryugu-like meteorites—inside a sample returned by Japan’s Hayabusa2 mission...

A recent study has shed light on the brain structure differences associated with psychopathy—a condition known to be one of the strongest predictors of persistent violent behavior.

The findings are published in the journal European Archives of Psychiatry and Clinical Neuroscience.

Using advanced neuroimaging and the Julich-Brain Atlas, researchers from Forschungszentrum Jülich, RWTH Aachen University, Heinrich-Heine-University Düsseldorf, Georg August University, (Germany) and University of Pennsylvania (U.S.) have identified specific brain networks that appear to be structurally altered in individuals exhibiting psychopathic traits. The Atlas can be freely accessed via the EBRAINS Research Infrastructure.

The study examined structural MRI data from 39 adult male particip...

Astronomers have uncovered a vast cloud of energetic particles—a “mini halo”—surrounding one of the most distant galaxy clusters ever observed, marking a major step forward in understanding the hidden forces that shape the cosmos.

The mini-halo is at a distance so great that it takes light 10 billion years to reach Earth, making it the most distant ever found, doubling the previous dista...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic migraines who took liraglutide, a GLP-1 receptor agonist, experienced over 50% fewer headache days and significantly improved daily functioning without meaningful weight loss. Researchers believe the drugs ability to lower brain fluid pressure is the key, potentially opening a completely new way to treat migraines. The effects were fast, sustained, and came with only mild side effects.

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at the European Academy of Neurology (EAN) Congress 2025.1

Researchers at the Headache Center of the University of Naples “Federico II” ...